Acute Effects of Modafinil on Brain Resting State Networks in Young Healthy Subjects Roberto Esposito 1,2. , Franco Cilli 2. , Valentina Pieramico 2 , Antonio Ferretti 1 , Antonella Macchia 3 , Marco Tommasi 3 , Aristide Saggino 3 , Domenico Ciavardelli 2,4 , Antonietta Manna 1 , Riccardo Navarra 1 , Filippo Cieri 1 , Liborio Stuppia 3 , Armando Tartaro 1 , Stefano L. Sensi 1,2,5,6 * 1 Department of Neuroscience and Imaging, University ‘‘G. d’Annunzio’’ Chieti-Pescara, Italy, 2 Molecular Neurology Unit, Center of Excellence on Aging, University ‘‘G. d’Annunzio’’ Chieti-Pescara, Italy, 3 Department of Psychological sciences, University ‘‘G. d’Annunzio’’ Chieti-Pescara, Italy, 4 School of Engineering, Architecture, and Motor Science, Kore University of Enna, Enna, Italy, 5 Departments of Neurology and Pharmacology, University of California-Irvine, Irvine, California, United States of America, 6 Institute for Mind Impairments and Neurological Disorders, University of California-Irvine, Irvine, California, United States of America Abstract Background: There is growing debate on the use of drugs that promote cognitive enhancement. Amphetamine-like drugs have been employed as cognitive enhancers, but they show important side effects and induce addiction. In this study, we investigated the use of modafinil which appears to have less side effects compared to other amphetamine-like drugs. We analyzed effects on cognitive performances and brain resting state network activity of 26 healthy young subjects. Methodology: A single dose (100 mg) of modafinil was administered in a double-blind and placebo-controlled study. Both groups were tested for neuropsychological performances with the Raven’s Advanced Progressive Matrices II set (APM) before and three hours after administration of drug or placebo. Resting state functional magnetic resonance (rs-FMRI) was also used, before and after three hours, to investigate changes in the activity of resting state brain networks. Diffusion Tensor Imaging (DTI) was employed to evaluate differences in structural connectivity between the two groups. Protocol ID: Modrest_2011; NCT01684306; http://clinicaltrials.gov/ct2/show/NCT01684306. Principal Findings: Results indicate that a single dose of modafinil improves cognitive performance as assessed by APM. Rs- fMRI showed that the drug produces a statistically significant increased activation of Frontal Parietal Control (FPC; p,0.04) and Dorsal Attention (DAN; p,0.04) networks. No modifications in structural connectivity were observed. Conclusions and Significance: Overall, our findings support the notion that modafinil has cognitive enhancing properties and provide functional connectivity data to support these effects. Trial Registration: ClinicalTrials.gov NCT01684306 http://clinicaltrials.gov/ct2/show/NCT01684306. Citation: Esposito R, Cilli F, Pieramico V, Ferretti A, Macchia A, et al. (2013) Acute Effects of Modafinil on Brain Resting State Networks in Young Healthy Subjects. PLoS ONE 8(7): e69224. doi:10.1371/journal.pone.0069224 Editor: Ben J. Harrison, The University of Melbourne, Australia Received December 1, 2012; Accepted June 5, 2013; Published July 25, 2013 Copyright: s 2013 Esposito et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: SLS is supported by funds from the Italian Department of Education [Fondo per gli Investimenti della Ricerca di Base (FIRB) 2003; Programmi di Ricerca di Rilevante Interesse nazionale (PRIN) 2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: SLS is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. * E-mail: ssensi@uci.edu . These authors contributed equally to this work. norepinephrine [1]. Finally, recent studies have shown that modafinil can also block the dopamine transporter (DAT1), thereby increasing brain dopamine levels [10]. The employment of psychostimulants to promote cognitive enhancement has been recently widely debated [11]. Among the drugs that have gathered some interest as cognitive enhancers, modafinil has emerged as a potential pharmacological aid to enhance performance in domains like attention and memory [12– 14]. However, to date, the potential of this drug as modulator of fluid intelligence (Gf) is still unknown. In this study, we aimed at filling this knowledge gap and evaluated effects of a single dose of Introduction Modafinil (Provigil), a drug on the market since 1997, is employed for the treatment of narcolepsy and other sleep disorders [1], [2]. In recent years, modafinil has also been used off-label to treat cognitive dysfunction in psychiatric disorders such as schizophrenia and the Attention Deficit/Hyperactivity Disorder (ADHD) [3–5]. Modafinil is involved in the modulation of orexin, a hypotha- lamic neuropeptide [6] that regulates wakefulness. Several studies have also indicated that the drug interferes with the activity of additional neurotransmitters like hypocretin, histamine [7], gamma-aminobutyric acid (GABA) [8], glutamate [9], and PLOS ONE | www.plosone.org July 2013 | Volume 8 | Issue 7 | e69224